Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

United Therapeutics Corp (NASDAQ:UTHR)

131.59
Delayed Data
As of Jun 23
 -0.11 / -0.08%
Today’s Change
97.52
Today|||52-Week Range
169.89
-8.25%
Year-to-Date

Today’s Trading

Previous close131.70
Today’s open131.86
Day’s range130.76 - 132.87
Volume1,195,642
Average volume (3 months)612,299
Market cap$5.9B
Dividend yield--
Data as of 3:59pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)+19.89%
Earnings growth (this year)-7.59%
Earnings growth (next 5 years)-6.70%
Revenue growth (last year)+9.08%
P/E ratio9.2
Price/Sales4.20
Price/Book3.05

Competitors

 Today’s
change
Today’s
% change
GRFSGrifols SA-0.25-1.11%
VRXValeant Pharmaceutic...+0.30+1.94%
PTHNPatheon NV+0.05+0.14%
IONSIonis Pharmaceutical...+0.25+0.46%
Data as of 4:02pm ET, 06/23/2017

Financials

Next reporting dateJuly 27, 2017
EPS forecast (this quarter)$3.49
Annual revenue (last year)$1.6B
Annual profit (last year)$713.7M
Net profit margin44.64%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Martine A. Rothblatt
President &
Chief Operating Officer
Michael Benkowitz
Corporate headquarters
Silver Spring, Maryland

Forecasts